Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems,... read more Featured Products: More products

Download Mobile App




3D Breast Tomosynthesis Provides Superior Sensitivity for Architectural Distortions and Masses

By HospiMedica International staff writers
Posted on 24 Jul 2013
A new breast tomosynthesis system is a three-dimensional (3D) imaging technology that uses a low-dose short X-ray sweep around the compressed breast with only nine exposures. More...
The new system provides very high sensitivity for architectural distortions and masses, providing more clinical effectiveness while delivering the same amount of radiation dose as a digital mammography acquisition of the same view.

The SenoClaire system, powered by ASiR (adaptive statistical iterative reconstruction) digital breast tomosynthesis (DBT) and developed by GE Healthcare (Chalfont St, Giles, UK), enhances mammographic specificity by improving lesion margin visibility. Because of its low dose and non-inferior clinical accuracy, SenoClaire has the potential to replace digital mammography exams in screening at half the dose to help in the identification of breast cancer. An additional craniocaudal (CC) view, as part of the learning curve process may be considered along with the 3D mediolateral-oblique (MLO) view, which will help radiologists become more comfortable with reviewing only the 3D MLO sequence in the near future.

SenoClaire enables optimized characterization of malignant and benign findings by providing a 3D MLO view that has excellent detection for architectural distortions and masses when compared with 2D full field digital mammography (FFDM). Clinical findings have demonstrated that the recall rate after a 3D MLO examination is lower than the recall rate after a 2D FFDM exam.

The detector offers high detective quantum efficiency (DQE) at a low dose for visualizing microcalcifications without binning, a process that regroups pixels for faster readout speeds and improved signal-to-noise ratios, but with reduced image quality. Step-and-shoot tube motion maintains microcalcification sharpness and avoids image blur, because the tube makes a complete stop for each of the nine exposures. This provides higher peak contrast for microcalcifications than conventional continuous tube motion.

An antiscatter solution designed for tomosynthesis, the SenoClaire grid in 3D reduces scattered radiation and improves detectability in 3D for breasts of above-average thickness, while preserving dose and performance. The system uses ASiRDBT, an iterative reconstruction algorithm that generates FFDM-like images and positively impacts microcalcification conspicuity versus the conventional filtered back projection (FBP) algorithm.

Because GE builds the Senographe with upgradability in mind, the system can easily be expanded as the department needs and capabilities grow. SenoClaire 3D breast tomosynthesis, stereotaxy, or SenoBright contrast-enhanced spectral mammography are fully compatible with any Senographe Essential and Senographe Care. The system’s images are compatible with major picture archiving and communication system (PACS) providers (with local variability), allowing integration into an existing setting, making optimal use of the investment.

With the IDI MammoWorkstation, radiologists can easily navigate through the DBT dataset using customized 2D/3D hanging protocols and specific ergonomic features: clear-cut visual identification of all series of tomosynthesis planes and slabs; dedicated tools to review tomosynthesis data sets: cine loop, bookmarks, breast localizer, breast height ruler; and V-Preview reconstructed images from tomosynthesis.

A requirement of dose performance entails that patient X-ray dose is kept as low as reasonably acceptable. A single MLO view of SenoClaire, powered by ASiRDBT, provides clinical non-inferiority when compared to two-view digital mammography. The system provides half the dose, with one single compression. SenoClaire’s ASiRDBT iterative reconstruction algorithm provides FFDM-like images and effectively impacts microcalcification conspicuity versus the conventional filtered back projection (FBP) algorithm.

SenoClaire’s 3D MLO sequence requires only nine exposures with an even distribution of the dose. The SenoClaire grid in 3D reduces scattered radiation and improves detectability in 3D for breasts of above-average thickness, while preserving dose and performance.

The dual-track X-ray tube (Mo/Rh) delivers optimal X-ray spectra to penetrate the breast based on breast density and compressed breast thickness. Automatic optimization of parameters (AOP) helps in the identification of the densest breast regions and automatically selects the correct anode, filter, kV, and mAs to ensure repeatable image quality at optimized radiation dose.

Related Links:

GE Healthcare



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Gold Member
Blood Gas Analyzer
i-Check200
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image

Explainable AI Tool Improves Brain Disorder Screening from 4D fMRI

Functional magnetic resonance imaging (fMRI) captures changes in brain activity over time, but the resulting image sequences can be difficult to analyze. Screening for brain disorders requires assessing... Read more

Critical Care

view channel
Image: Liposomes have long been used for gradual drug delivery, with their composition controlling release speed, potency, duration, and potential toxicity. (Image Credit: iStock)

New Drug Delivery System Extends Release of Local Anesthetic for Weeks

Local anesthetics used for nerve blocks often provide pain relief for only a limited period, while perioperative pain can persist much longer. Extending the duration of a nerve block therefore requires... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.